ATCvet code QG51
| ATC codes |
|---|
| G Genito-urinary system and sex hormones |
| G01 Gynecological antiinfectives and antiseptics |
| G02 Other gynecologicals |
| G03 Sex hormones and modulators of the genital system |
| G04 Urologicals |
| ATCvet only |
| QG51 Antiinfectives and antiseptics for intrauterine use |
| QG52 Products for teats and udder |
|
|
ATCvet code QG51 Antiinfectives and antiseptics for intrauterine use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products for veterinary use.[1][2] Subgroup QG51 is part of the anatomical group QG Genito-urinary system and sex hormones.[3]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
QG51A Antiinfectives and antiseptics for intrauterine use
QG51AA Antibacterials
- QG51AA01 Oxytetracycline
- QG51AA02 Tetracycline
- QG51AX03 Amoxicillin
- QG51AA04 Gentamicin
- QG51AX05 Cefapirin
- QG51AA06 Rifaximin
- QG51AA07 Cefquinome
- QG51AA08 Chlortetracycline
- QG51AA09 Formosulfathiazole
QG51AD Antiseptics
- QG51AD01 Povidone-iodine
- QG51AD02 Policresulen
- QG51AD03 Peroxy-acetic acid
- QG51AD30 Combinations of antiseptics
QG51AG Antiinfectives and/or antiseptics, combinations for intrauterine use
- QG51AG01 Procaine benzylpenicillin, dihydrostreptomycin and sulfadimidine
- QG51AG02 Benzylpenicillin, dihydrostreptomycin and sulfadimidine
- QG51AG03 Tetracycline, neomycin and sulfadimidine
- QG51AG04 Ampicillin and oxacillin
- QG51AG05 Ampicillin and cloxacillin
- QG51AG06 Oxytetracycline and neomycin
- QG51AG07 Ampicillin and colistin
References
- ↑ "The ATCvet classification system" (PDF). European Medicines Agency. Retrieved 1 February 2020.
- ↑ "ATCvet Code, ein Klassierungssystem für Tierarzneimittel" (in German). University of Zurich. Retrieved 1 February 2020.
- ↑ "ATCvet Index 2022: code QG51". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.